Aptus Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
9,095
+2,732
+43% +$568K 0.01% 496
2026
Q1
$1.34M Buy
6,363
+2,993
+89% +$645K 0.01% 541
2025
Q4
$693K Buy
3,370
+803
+31% +$151K 0.01% 663
2025
Q3
$403K Sell
2,567
-1,415
-36% -$219K ﹤0.01% 757
2025
Q2
$669K Buy
3,982
+288
+8% +$42.7K 0.01% 616
2025
Q1
$509K Sell
3,694
-102
-3% -$13K 0.01% 636
2024
Q4
$449K Buy
3,796
+1,877
+98% +$219K ﹤0.01% 665
2024
Q3
$212K Sell
1,919
-152
-7% -$15.9K ﹤0.01% 749
2024
Q2
$204K Buy
2,071
+100
+5% +$10.2K ﹤0.01% 732
2024
Q1
$221K Buy
+1,971
New +$213K ﹤0.01% 710

Other funds holding CAH

Aptus Capital Advisors's CAH Position: Q2 2026 in Review

Aptus Capital Advisors increased its Cardinal Health (CAH) stake by 43% in Q2 2026, buying an estimated $568K and bringing the position to 9,095 shares worth $2.16M. The position accounts for 0.01% of the portfolio, ranked #496.

Aptus Capital Advisors first reported a position in CAH in Q1 2024 and has held it in 10 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Aptus Capital Advisors held 9,095 shares of Cardinal Health worth $2.16M as of Q2 2026.
  • Aptus Capital Advisors bought 2,732 Cardinal Health shares in Q2 2026, an estimated $568K.
  • Cardinal Health made up 0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #496 holding.
  • Aptus Capital Advisors first reported a position in Cardinal Health in Q1 2024 and has held it in 10 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.